A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1) - Ramalingam, Suresh; Schmid-Bindert, Gerald (Annals of oncology, 2015)
Gesehen am 19.02.2018